Ben-Menachem, E., Axelsen, M., Johanson, E
From the doseinhibition curves established in vitro, circulating GLP-1(936) (~30 pmol/l) can be expected to inhibit glucagon secretion by up to 80%, making it difficult to observe any additional suppression by exogenous administration (especially under normoglycaemic conditions when glucagon secretion is already strongly reduced) (schematic Fig
Lead (Pb)-induced oxidative stress and toxicity reduced the expression of selenoprotein mRNAs, and the effect was mitigated by selenium supplementation 129
The platform's self-published outcome figures and review numbers represent the company's claims and haven't been independently verified
Additionally, oleogels have been investigated as substitutes for unhealthy saturated and trans FAs (Davidovich-Pinhas 2016)